ArticleMolecular therapy. Nucleic acids2022

CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease

Evangelos Konstantinidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.